[Radioimmunoassay of carcinoembryogenic antigen (CEA) in patients with carcinoma. Conclusion from preliminary results of a collaborative study in Switzerland].
D000941:Antigens / Q000032:analysis*; D001943:Breast Neoplasms / Q000276:immunology; D002272:Carcinoembryonic Antigen / Q000032:analysis; D003110:Colonic Neoplasms / Q000276:immunology; D003429:Cross Reactions; D004622:Embryo, Mammalian / Q000276:immunology; D000939:Epitopes; D004938:Esophageal Neoplasms / Q000276:immunology; D005770:Gastrointestinal Neoplasms / Q000276:immunology*; D006801:Humans; D007106:Immune Sera; D010190:Pancreatic Neoplasms / Q000276:immunology; D011863:Radioimmunoassay; D012004:Rectal Neoplasms / Q000276:immunology
D000941:Antigens; D002272:Carcinoembryonic Antigen; D000939:Epitopes; D007106:Immune Sera
Dosage radio-immunologique de l'antigène carcinoembryonnaire (CEA) dans le plasma de malades atteints de carcinomes. Conclusion des premiers résultats d'une étude collaborative en Suisse.